Has the consistency evaluation policy of generic drugs promoted the innovation quality of Chinese pharmaceutical manufacturing industry? An empirical study based on the difference-in-differences model
IntroductionIn March 2016, the Chinese government officially launched a nationwide consistency evaluation of the quality and efficacy of generic drugs.MethodsThis paper conducted an empirical study using the Difference-in-Differences method to explore the effect of this policy on the innovation qual...
Saved in:
Main Authors: | Qiang Liu (Author), Zhe Huang (Author), Zhenbin Mao (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Impact of the Consistency Evaluation Policy of Generic Drugs on R&D Investment Intensity of Pharmaceutical Companies-An Empirical Study Based on the Difference-in-Differences Model
by: Yanyi Wei, et al.
Published: (2022) -
The Influence of Industrial Structure Upgrade on Coupling and Coordinated Development-Empirical Analysis From Chinese Pharmaceutical Manufacturing and Pharmaceutical Service Industries
by: Meng Hu, et al.
Published: (2021) -
Measure on innovation efficiency of China's pharmaceutical manufacturing industry
by: Shen Zhong, et al.
Published: (2022) -
The impact of centralized band purchasing of pharmaceuticals on innovation of Chinese pharmaceutical firms: an empirical study based on double difference models
by: Xinqing Chen, et al.
Published: (2024) -
Pharmaceutical equivalency of locally and regionally manufactured generic pharmaceutical products in UAE
by: Lamia Al Ali, et al.
Published: (2022)